Tyrus Capital S.A.M.’s AbbVie ABBV Stock Holding History

Tyrus Capital S.A.M.’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q2	–	Sell	-425,000	Closed	-$24.9M	–	14
2015 Q1	$24.9M	Buy	+425,000	New	+$25.7M	2.77%	17

Other funds holding ABBV

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

JHIU

Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return

Tyrus Capital S.A.M.'s ABBV Position: Q2 2015 in Review

Tyrus Capital S.A.M. sold out of AbbVie (ABBV) in Q2 2015, closing a stake of 425,000 shares — an estimated $24.9M sold.

Tyrus Capital S.A.M. first reported a position in ABBV in Q1 2015 and held it in 1 quarter. The position peaked at $24.9M in Q1 2015. 1,652 funds tracked by Wall St. Rank hold ABBV as of Q2 2015.

Tyrus Capital S.A.M. reported no remaining AbbVie position as of Q2 2015 after selling out during the quarter.
Tyrus Capital S.A.M. sold 425,000 AbbVie shares in Q2 2015, an estimated $24.9M.
Tyrus Capital S.A.M. first reported a position in AbbVie in Q1 2015 and held it in 1 quarter.
Tyrus Capital S.A.M.'s AbbVie position peaked at $24.9M in Q1 2015.
1,652 funds tracked by Wall St. Rank held AbbVie as of Q2 2015.

Based on Tyrus Capital S.A.M.'s 13F filing for Q2 2015, filed 14 Aug 2015.